This study evaluated a cohort of children ages 1-36 months in communities randomized to biannual treatment of children with azithromycin or placebo.
While evaluations on the implementation of the SAFE strategy have been done, systematic reviews on the factors that have shaped implementation are lacking. This review sought to identify these factors.
This study tested the hypothesis that an automated algorithm could classify eyelid photographs better than chance.
This study aims to quantify and characterize research activity and treatment availability for NTDs in children in order to inform the prioritization of future research efforts.
Program decision-making for trachoma elimination currently relies on conjunctival clinical signs. Antibody tests may provide additional information on the epidemiology of trachoma, particularly in regions where it is disappearing or elimination targets have been met.
This study explored factors associated with individual MDA participation at the individual, head of household, and household levels in Amhara, Ethiopia.
This study looks at the prevalence of self-reported side effects was assessed among those who self-reported receiving azithromycin 3 weeks following the 2016 trachoma MDA in Amhara, Ethiopia
This article looks at how economic developing is helping Ghana to accelerate towards its NTD targets through health system strengthening and mobile health activities.
This study provides a pooled analysis of all published cluster-randomized trials evaluating the effect of azithromycin MDA on child mortality.
This study explores the ethics of mass azithromycin administration to reduce all cause mortality in children in light of issues related to rational antibiotic use and the adverse consequences of increased antibiotic resistance.